These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30024638)

  • 1. Postanalytical considerations that may improve the diagnosis or exclusion of haemophilia and von Willebrand disease.
    Favaloro EJ; Mohammed S; Lippi G
    Haemophilia; 2018 Nov; 24(6):849-861. PubMed ID: 30024638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preanalytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease.
    Favaloro EJ; Lippi G
    Haemophilia; 2018 Mar; 24(2):198-210. PubMed ID: 29271545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential misdiagnosis of von Willebrand disease and haemophilia caused by ineffective mixing of thawed plasma.
    Favaloro EJ; Oliver S; Mohammed S; Ahuja M; Grzechnik E; Azimulla S; McDonald J; Lima-Oliveira G; Lippi G
    Haemophilia; 2017 Sep; 23(5):e436-e443. PubMed ID: 28750474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1.
    Schneppenheim R; Budde U; Krey S; Drewke E; Bergmann F; Lechler E; Oldenburg J; Schwaab R
    Thromb Haemost; 1996 Oct; 76(4):598-602. PubMed ID: 8903002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease.
    Lassila R; Holme PA; Landorph A; Petrini P; Onundarson PT; Hillarp A
    Semin Thromb Hemost; 2011 Jul; 37(5):495-502. PubMed ID: 22102192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory methods for the genetic diagnosis of bleeding disorders.
    Goodeve AC
    Clin Lab Haematol; 1998 Feb; 20(1):3-19. PubMed ID: 9681206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand disease and platelet disorders.
    Favaloro EJ; Bodó I; Israels SJ; Brown SA
    Haemophilia; 2014 May; 20 Suppl 4():59-64. PubMed ID: 24762277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: A large international cross-laboratory study.
    Favaloro EJ; Bonar R; Hollestelle MJ; Jennings I; Mohammed S; Meijer P; Woods T; Meiring M
    Thromb Res; 2018 Jun; 166():96-105. PubMed ID: 29727738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
    Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J
    Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected presentation of type 2N von Willebrand disease in pregnancy.
    Dennis MW; Clough V; Toh CH
    Haemophilia; 2000 Nov; 6(6):696-7. PubMed ID: 11122399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of hemophilia and von Willebrand-Jürgens syndrome. 1. Organization of a dispensary for patients with hemorrhagic diatheses and a laboratory program].
    Lutze G; Schlote A
    Z Gesamte Inn Med; 1985 Aug; 40(15):441-5. PubMed ID: 3877377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, diagnosis, and management of von Willebrand disease in India.
    Ghosh K; Shetty S
    Semin Thromb Hemost; 2011 Jul; 37(5):595-601. PubMed ID: 22102205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity.
    Lasne D; Dey C; Dautzenberg MD; Cherqaoui Z; Monge F; Aouba A; Torchet MF; Geloen D; Landais P; Rothschild C
    Haemophilia; 2012 May; 18(3):e158-63. PubMed ID: 21951857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
    Favaloro EJ
    Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments in the diagnostic procedures for von Willebrand disease.
    De Jong A; Eikenboom J
    J Thromb Haemost; 2016 Mar; 14(3):449-60. PubMed ID: 26714181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type 2N von Willebrand disease (Normandy)].
    Morales-De la Vega A; Reyes-Maldonado E; Martínez-Murillo C; Quintana-González S
    Rev Med Inst Mex Seguro Soc; 2008; 46(1):55-62. PubMed ID: 18647572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What have we learned from large population studies of von Willebrand disease?
    Montgomery RR; Flood VH
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):670-677. PubMed ID: 27913545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand disease masquerading as haemophilia A.
    Mazurier C
    Thromb Haemost; 1992 Apr; 67(4):391-6. PubMed ID: 1631785
    [No Abstract]   [Full Text] [Related]  

  • 20. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.
    Kumar R; Carcao M
    Pediatr Clin North Am; 2013 Dec; 60(6):1419-41. PubMed ID: 24237980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.